Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Jardine Matheson Holdings ( (GB:JAR) ) is now available.
Jardine Matheson Holdings has disclosed a series of share acquisitions under its scrip dividend scheme involving director Ben Keswick, several closely associated family members, and family trusts. The transactions, conducted on 13 May 2026 outside a trading venue, include the purchase of ordinary shares at about US$72.58 each, increasing insider and family-related trust holdings and signalling continued alignment of senior leadership with shareholders.
Additional acquisitions were made by Butterfield Trust (Bermuda) Limited acting as trustee for family trusts associated with directors Ben and Adam Keswick, further consolidating family-linked ownership in the group. While routine in nature, these disclosures highlight ongoing use of the scrip dividend mechanism and offer investors greater transparency over insider participation in the company’s equity, potentially reinforcing confidence in its long-term outlook and governance.
The most recent analyst rating on (GB:JAR) stock is a Buy with a $94.00 price target. To see the full list of analyst forecasts on Jardine Matheson Holdings stock, see the GB:JAR Stock Forecast page.
More about Jardine Matheson Holdings
Jardine Matheson Holdings Limited is a diversified Asian-focused conglomerate with interests spanning retail, property, hotels, motor trading, and other services. Listed in Bermuda with a significant presence in Hong Kong and Southeast Asia, the group manages a portfolio of operating companies and investments across multiple sectors and markets.
Average Trading Volume: 2,598
Technical Sentiment Signal: Buy
Current Market Cap: $21.59B
For a thorough assessment of JAR stock, go to TipRanks’ Stock Analysis page.